HLS vs NTI

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

49LOW

NTI

NEUROTECH FPO [NTI]

51MEDIUM

Score Breakdown

HLS NTI
Technical
42
61
Catalyst
76
53
Sentiment
50
50
Fundamental
90
72
Momentum
28
56
Risk Gate
32
31

Key Metrics

HLS Metric NTI
$257.8MMarket Cap$23.7M
3.1MAvg Volume (20d)2.5M
+10.3%Short InterestN/A
$1.07052-Week High$0.029
$0.30052-Week Low$0.010
+0.0%Daily Change-5.6%
$0.360Reference Price$0.017
-69.3%ROE-66.3%
-12.3%Profit Margin-54.4%

Active Signals

HLS Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Drifting lower — down 7.7% over the last 5 days
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.2x)

NTI Signals

●Trading above both moving averages — the trend is your friend here
●Above-average volume (1.7x) on a red day — sellers in control
●Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)
●Low P/S ratio (3.4x)
●Strong revenue growth (+4069%)
●Small-cap ($20-100M)

Ask Scout AI to compare HLS and NTI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HLS vs NXN →HLS vs NYR →HLS vs OCC →HLS vs ONE →HLS vs PAR →
HLS Full Analysis → NTI Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).